批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/02/10 |
SUPPL-106(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/12/24 |
SUPPL-91(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/06/17 |
SUPPL-89(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/01/31 |
SUPPL-82(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/08/23 |
SUPPL-74(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/04/28 |
SUPPL-67(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/05/18 |
SUPPL-61(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2016/03/03 |
SUPPL-60(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/07/17 |
SUPPL-58(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/04/30 |
SUPPL-59(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/12/13 |
SUPPL-57(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/11/08 |
SUPPL-56(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/09/16 |
SUPPL-55(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/07/23 |
SUPPL-54(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2012/08/20 |
SUPPL-53(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2009/05/19 |
SUPPL-47(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/09/26 |
SUPPL-44(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/12/17 |
SUPPL-25(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/12/19 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/08/21 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/06/28 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/04/16 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/02/20 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2001/08/27 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2001/01/11 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/05/11 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/12/15 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/11/05 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/05/25 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1997/01/24 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1996/07/25 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1995/08/03 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1989/03/02 |
SUPPL-1(补充) |
Approval |
Labeling |
|
|
|
1987/12/22 |
ORIG-1(原始申请) |
Approval |
Type 5 - New Formulation or New Manufacturer |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:EPINEPHRINE 剂型/给药途径:INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 规格:0.3MG/DELIVERY 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
019430 |
001 |
NDA |
EPIPEN |
EPINEPHRINE |
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS |
0.3MG/DELIVERY |
Prescription |
Yes |
Yes |
AB |
1987/12/22
|
MYLAN SPECIALITY LP |
090589 |
001 |
ANDA |
EPINEPHRINE (AUTOINJECTOR) |
EPINEPHRINE |
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS |
0.3MG/DELIVERY |
Prescription |
No |
No |
AB |
2018/08/16
|
TEVA PHARMS USA |
活性成分:EPINEPHRINE 剂型/给药途径:INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 规格:0.15MG/DELIVERY 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
019430 |
002 |
NDA |
EPIPEN JR. |
EPINEPHRINE |
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS |
0.15MG/DELIVERY |
Prescription |
Yes |
Yes |
AB |
1987/12/22
|
MYLAN SPECIALITY LP |
090589 |
002 |
ANDA |
EPINEPHRINE (AUTOINJECTOR) |
EPINEPHRINE |
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS |
0.15MG/DELIVERY |
Prescription |
No |
No |
AB |
2018/08/16
|
TEVA PHARMS USA |